Linezolid
Linezolid comes in 12 pill versions in our database, in 1 strength, from 12 manufacturers. Check the imprint to tell them apart.
Linezolid pill images
600 mg 12 pills
-
I 22
Linezolid 600 mg
White, oval, 18 mm
Used for pneumonia and skin infections
- ZYVOX 600mg Linezolid 600 mg White, capsule, 18 mm Used for pneumonia and skin infections
- n022 Linezolid 600 mg White, oval, 18 mm Used for pneumonia and skin infections
- L340 Linezolid 600 mg White, oval, 19 mm Used for pneumonia and skin infections
- LIN600 Linezolid 600 mg White, capsule, 18 mm Used for pneumonia and skin infections
- CIC 1 Linezolid 600 mg White, oval, 18 mm Used for pneumonia and skin infections
- ZYV 600 Linezolid 600 mg White, capsule, 18 mm Used for pneumonia and skin infections
- R561 Linezolid 600 mg Yellow, oval, 19 mm Used for pneumonia and skin infections
- F32 Linezolid 600 mg White, capsule, 18 mm Used for pneumonia and skin infections
- LZ600 Linezolid 600 mg White, oval Used for pneumonia and skin infections
- APO LIN600 Linezolid 600 mg White, oval Used for pneumonia and skin infections
- 600 JP Linezolid 600 mg White, capsule Used for pneumonia and skin infections
What is Linezolid used for?
Linezolid is used for pneumonia and skin infections.
- Medicine type
- Antibiotic
Official uses from the US prescribing label
Nosocomial Pneumonia
Linezolid is indicated for the treatment of nosocomial pneumonia caused by Staphylococcus aureus (methicillin-susceptible and -resistant isolates) or Streptococcus pneumoniae.
Community-acquired Pneumonia
Linezolid is indicated for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, including cases with concurrent bacteremia, or Staphylococcus aureus (methicillin-susceptible isolates only).
Complicated Skin and Skin Structure Infections
Linezolid is indicated for the treatment of complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis, caused by Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus pyogenes, or Streptococcus agalactiae. Linezolid has not been studied in the treatment of decubitus ulcers.
Uncomplicated Skin and Skin Structure Infections
Linezolid is indicated for the treatment of uncomplicated skin and skin structure infections caused by Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes.
Vancomycin-resistant Enterococcus faecium Infections
Linezolid is indicated for the treatment of vancomycin-resistant Enterococcus faecium infections, including cases with concurrent bacteremia.
Limitations of Use
- Linezolid is not indicated for the treatment of Gram-negative infections. It is critical that specific Gram-negative therapy be initiated immediately if a concomitant Gram-negative pathogen is documented or suspected.
- The safety and efficacy of linezolid formulations given for longer than 28 days have not been evaluated in controlled clinical trials.
Usage
To reduce the development of drug-resistant bacteria and maintain the effectiveness of linezolid and other antibacterial drugs, linezolid should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
From the FDA-approved label on DailyMed (published Sep 04, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.